1. Home
  2. CENN vs MRNS Comparison

CENN vs MRNS Comparison

Compare CENN & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CENN
  • MRNS
  • Stock Information
  • Founded
  • CENN 2013
  • MRNS 2003
  • Country
  • CENN United States
  • MRNS United States
  • Employees
  • CENN N/A
  • MRNS N/A
  • Industry
  • CENN Auto Manufacturing
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CENN Consumer Discretionary
  • MRNS Health Care
  • Exchange
  • CENN Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • CENN 32.4M
  • MRNS 29.9M
  • IPO Year
  • CENN N/A
  • MRNS 2014
  • Fundamental
  • Price
  • CENN $1.00
  • MRNS $0.55
  • Analyst Decision
  • CENN
  • MRNS Buy
  • Analyst Count
  • CENN 0
  • MRNS 12
  • Target Price
  • CENN N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • CENN 120.8K
  • MRNS 1.2M
  • Earning Date
  • CENN 02-25-2025
  • MRNS 03-04-2025
  • Dividend Yield
  • CENN N/A
  • MRNS N/A
  • EPS Growth
  • CENN N/A
  • MRNS N/A
  • EPS
  • CENN N/A
  • MRNS N/A
  • Revenue
  • CENN $37,052,841.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • CENN N/A
  • MRNS $14.97
  • Revenue Next Year
  • CENN N/A
  • MRNS $57.65
  • P/E Ratio
  • CENN N/A
  • MRNS N/A
  • Revenue Growth
  • CENN 142.48
  • MRNS 1.63
  • 52 Week Low
  • CENN $0.97
  • MRNS $0.22
  • 52 Week High
  • CENN $2.30
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CENN 29.40
  • MRNS 70.71
  • Support Level
  • CENN $0.99
  • MRNS $0.54
  • Resistance Level
  • CENN $1.07
  • MRNS $0.55
  • Average True Range (ATR)
  • CENN 0.05
  • MRNS 0.00
  • MACD
  • CENN -0.01
  • MRNS -0.01
  • Stochastic Oscillator
  • CENN 13.64
  • MRNS 100.00

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles. Its vehicles include Metro, Logistar 400, Logistar 200, Neibor 200, and ORV. The company's geographical segments include Europe, America, and Asia.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: